Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-028213
Filing Date
2024-11-27
Accepted
2024-11-27 18:14:41
Documents
1
Period of Report
2024-11-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 10597
  Complete submission text file 0001127602-24-028213.txt   12121
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O PROVENTION BIO, INC. P.O. BOX 666 OLDWICK NJ 08858
Business Address
Bluestone Jeffrey (Reporting) CIK: 0001771814 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 241512747